BioTuesdays publishes interview with Pacylex CEO highlighting NMT inhibitor development

On May 26, BioTuesdays published their interview with Pacylex CEO highlighting NMT inhibitor development.

‍

The full article can be found here:

‍https://biotuesdays.com/2026/05/26/pacylex-reshaping-cancer-treatment-with-a-novel-once-daily-oral-therapy/?fbclid=IwY2xjawSNIN1leHRuA2FlbQIxMQBzcnRjBmFwcF9pZBAyMjIwMzkxNzg4MjAwODkyAAEe9lcSwoET_qYJK9bjh8UflW5K8BNgWcz7lZMihlnDuRTHS8EauKI7sGBSj7U_aem_qZ4X2LBqVrmWYFLKnzgSbg